NOTE 5 - STOCK WARRANTS AND OPTIONS | NOTE 5 – STOCK WARRANTS AND OPTIONS Stock Warrants During the three and six months ended June 30, 2021, no warrants were issued or exercised, and 2,050,000 warrants with an exercise price of $0.60 per share expired. On July 3, 2021, and effective retroactively to May 17, 2021 (the expiration date of such 2,050,000 warrants), the Board of Directors authorized and approved the extension of the expiration dates of such warrants to December 31, 2026. In addition, on July 3, 2021, the Board of Directors authorized and approved the extension of the expiration dates of (i) 1,290,000 warrants due to expire on August 9, 2021 with an exercise price of $0.60 per share, (ii) 100,000 warrants due to expire on September 9, 2021 with an exercise price of $0.75 per share, and (iii) 750,000 warrants due to expire on November 8, 2021 with an exercise price of $0.30 per share. The expiration dates of all such warrants were extended to December 31, 2026. On July 3, 2021, the Board of Directors also granted 250,000 warrants to each of the three directors which warrants have an exercise price of $0.30 per share and expire on December 31, 2026. During the three and six months ended June 30, 2020, no warrants were issued or exercised, and 533,334 warrants expired. Warrants outstanding and exercisable as June 30, 2021 (reflecting the retroactive effectiveness of the extension of 2,050,000 warrants described above) were: Weighted Average Exercisable Exercise Number of Remaining Number of Price Warrants Life in Years Warrants $ 0.60 3,590,000 3.2 3,590,000 $ 0.75 100,000 0.2 100,000 $ 0.50 - 0.0 - $ 0.30 750,000 0.4 750,000 4,440,000 4,440,000 During the three and six months ended June 30, 2021, $141,373 was recognized as stock-based compensation associated with the expiration extension of the 2,050,000 warrants. No stock-based compensation was recognized during the three and six months ended June 30, 2020. Stock Options In September 2003, shareholders of the Company approved an employee stock option plan (the “2003 Option Plan”) authorizing the issuance of options to purchase up to 1,000,000 shares of common stock. The 2003 Option Plan is intended to give the Company greater ability to attract, retain, and motivate officers, key employees, directors and consultants; and is intended to provide the Company with the ability to provide incentives more directly linked to the success of the Company’s business and increases in shareholder value. During the third quarter of 2013, the board of directors increased the number of shares reserved for issuance under the 2003 Option Plan from 1,000,000 to 1,250,000 which was increased by the board to 1,750,000 during the third quarter of 2018. On July 3, 2021, the Board of Directors authorized and approved the extension of the expiration dates of 141,667 options exercisable at $0.60 per share due to expire on August 9, 2021 for an additional term of five years, and authorized and approved the extension of 165,010 options exercisable at $0.30 per share due to expire on August 2, 2021 for an additional term of five years. In addition, on July 3, 2021, the Board also granted a total of 247,516 options to employees which options have an exercise price of $0.20 per share and expire five years thereafter, On July 21, 2021, the Board of Directors also authorized and approved the extension of 150,000 options exercisable at $0.30 per share due to expire on September 21, 2021 for an additional term of five years. A summary of the activity of the Company’s stock options for the six months ended June 30, 2021 is presented below: Weighted Weighted Weighted Average Average Average Number of Remaining Optioned Aggregate Exercise Optioned Contractual Grant Date Intrinsic Price Shares Term in Years Fair Value Value Balance as of December 31, 2020 $ 0.36 1,133,388 $ - $ - Expired - - - Granted - - - Exercised - - - Forfeited - - - Balance as of June 30, 2021 $ 0.36 1,133,388 1.06 $ 0.16 $ - Vested and exercisable as of June 30, 2021 $ 0.36 1,133,388 1.06 $ 0.16 $ - |